Prognostic factors impacting clinical outcome following Malassezia folliculitis treatment

Background: Malassezia folliculitis (MF) is a chronic disease that develops in the pilosebaceous unit, caused by Malassezia species. Patients’,characteristics, clinical manifestations, laboratory examination, and treatment choice affect the clinical recovery in patients with MF. This study aimed to...

Full description

Bibliographic Details
Main Authors: Widaty, Sandra, Miranda, Eliza, Menaldi, Sri Linuwih, Priyanto, Mufqi Handaru, Kusumawardani, Hening Tirta, Kekalih, Aria, Bramono, Kusmarinah
Format: Article
Language:English
Published: Iranian Society of Dermatology 2022
Subjects:
Online Access:https://repository.ugm.ac.id/283325/1/IJD_Volume%2025_Issue%201_Pages%209-16.pdf
_version_ 1797037676106350592
author Widaty, Sandra
Miranda, Eliza
Menaldi, Sri Linuwih
Priyanto, Mufqi Handaru
Kusumawardani, Hening Tirta
Kekalih, Aria
Bramono, Kusmarinah
author_facet Widaty, Sandra
Miranda, Eliza
Menaldi, Sri Linuwih
Priyanto, Mufqi Handaru
Kusumawardani, Hening Tirta
Kekalih, Aria
Bramono, Kusmarinah
author_sort Widaty, Sandra
collection UGM
description Background: Malassezia folliculitis (MF) is a chronic disease that develops in the pilosebaceous unit, caused by Malassezia species. Patients’,characteristics, clinical manifestations, laboratory examination, and treatment choice affect the clinical recovery in patients with MF. This study aimed to identify several potential factors that determine the treatment outcome of MF. Methods: This retrospective study was conducted at Dr. Cipto Mangunkusumo Hospital, Jakarta, from 2013 to 2017. Eligible patients diagnosed with MF based on clinical and microscopic examinations were included. Clinical outcomes were defined as complete cure or improvement with a decrease in the subjective symptoms (itchiness) and objective symptoms (lesions). Analyses were carried out using STATA version 5. 0, and some analyses and graphics were generated in R (version 3. 2. 2 for Windows), GraphPad Prism version 6. 01, and Microsoft Excel. Results: A total of 30 patients with MF were recruited. Several factors had a significant effect on the clinical outcomes such as predilection site (chest,HR 1. 422,95% CI 1. 262–, 1. 696,P = 0. 018), isolated systemic therapy (HR 1. 915, 95% CI 1. 441–, 2. 532,P = 0. 002), and combination therapy (HR 1. 858,95% CI 1. 350–, 2. 541,P = 0. 041). Conclusion: Lesions in the chest area, isolated systemic antifungal therapy, and combination therapy were associated with good outcomes following antifungal treatment.
first_indexed 2024-03-14T00:07:33Z
format Article
id oai:generic.eprints.org:283325
institution Universiti Gadjah Mada
language English
last_indexed 2024-03-14T00:07:33Z
publishDate 2022
publisher Iranian Society of Dermatology
record_format dspace
spelling oai:generic.eprints.org:2833252023-11-20T06:06:28Z https://repository.ugm.ac.id/283325/ Prognostic factors impacting clinical outcome following Malassezia folliculitis treatment Widaty, Sandra Miranda, Eliza Menaldi, Sri Linuwih Priyanto, Mufqi Handaru Kusumawardani, Hening Tirta Kekalih, Aria Bramono, Kusmarinah Dermatology Background: Malassezia folliculitis (MF) is a chronic disease that develops in the pilosebaceous unit, caused by Malassezia species. Patients’,characteristics, clinical manifestations, laboratory examination, and treatment choice affect the clinical recovery in patients with MF. This study aimed to identify several potential factors that determine the treatment outcome of MF. Methods: This retrospective study was conducted at Dr. Cipto Mangunkusumo Hospital, Jakarta, from 2013 to 2017. Eligible patients diagnosed with MF based on clinical and microscopic examinations were included. Clinical outcomes were defined as complete cure or improvement with a decrease in the subjective symptoms (itchiness) and objective symptoms (lesions). Analyses were carried out using STATA version 5. 0, and some analyses and graphics were generated in R (version 3. 2. 2 for Windows), GraphPad Prism version 6. 01, and Microsoft Excel. Results: A total of 30 patients with MF were recruited. Several factors had a significant effect on the clinical outcomes such as predilection site (chest,HR 1. 422,95% CI 1. 262–, 1. 696,P = 0. 018), isolated systemic therapy (HR 1. 915, 95% CI 1. 441–, 2. 532,P = 0. 002), and combination therapy (HR 1. 858,95% CI 1. 350–, 2. 541,P = 0. 041). Conclusion: Lesions in the chest area, isolated systemic antifungal therapy, and combination therapy were associated with good outcomes following antifungal treatment. Iranian Society of Dermatology 2022-03 Article PeerReviewed application/pdf en https://repository.ugm.ac.id/283325/1/IJD_Volume%2025_Issue%201_Pages%209-16.pdf Widaty, Sandra and Miranda, Eliza and Menaldi, Sri Linuwih and Priyanto, Mufqi Handaru and Kusumawardani, Hening Tirta and Kekalih, Aria and Bramono, Kusmarinah (2022) Prognostic factors impacting clinical outcome following Malassezia folliculitis treatment. Iranian Journal of Dermatology, 25 (1). pp. 9-16. ISSN 27170721 https://www.iranjd.ir/article_147726_d82bdea68f320783f3d5b1046edff0e6.pdf 10.22034/ijd.2021.256618.1266
spellingShingle Dermatology
Widaty, Sandra
Miranda, Eliza
Menaldi, Sri Linuwih
Priyanto, Mufqi Handaru
Kusumawardani, Hening Tirta
Kekalih, Aria
Bramono, Kusmarinah
Prognostic factors impacting clinical outcome following Malassezia folliculitis treatment
title Prognostic factors impacting clinical outcome following Malassezia folliculitis treatment
title_full Prognostic factors impacting clinical outcome following Malassezia folliculitis treatment
title_fullStr Prognostic factors impacting clinical outcome following Malassezia folliculitis treatment
title_full_unstemmed Prognostic factors impacting clinical outcome following Malassezia folliculitis treatment
title_short Prognostic factors impacting clinical outcome following Malassezia folliculitis treatment
title_sort prognostic factors impacting clinical outcome following malassezia folliculitis treatment
topic Dermatology
url https://repository.ugm.ac.id/283325/1/IJD_Volume%2025_Issue%201_Pages%209-16.pdf
work_keys_str_mv AT widatysandra prognosticfactorsimpactingclinicaloutcomefollowingmalasseziafolliculitistreatment
AT mirandaeliza prognosticfactorsimpactingclinicaloutcomefollowingmalasseziafolliculitistreatment
AT menaldisrilinuwih prognosticfactorsimpactingclinicaloutcomefollowingmalasseziafolliculitistreatment
AT priyantomufqihandaru prognosticfactorsimpactingclinicaloutcomefollowingmalasseziafolliculitistreatment
AT kusumawardaniheningtirta prognosticfactorsimpactingclinicaloutcomefollowingmalasseziafolliculitistreatment
AT kekaliharia prognosticfactorsimpactingclinicaloutcomefollowingmalasseziafolliculitistreatment
AT bramonokusmarinah prognosticfactorsimpactingclinicaloutcomefollowingmalasseziafolliculitistreatment